NEW YORK STOCK EXCHANGE, INC. · JNJ

+0.99% · +$2.63 · Vol 5.8M

Market closed · last close 4:00 PM ET · price as of 19:49:23 ET

Johnson & Johnson

Pharmaceuticals

$268.40

Card

Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factors

Fri Aug 28 · last completed session · Markets closed · resumes Mon 9:30 ET · JNJ

Methodology

JNJ

Johnson & Johnson

Fri Aug 28 · last completed session · Markets closed · resumes Mon 9:30 ET

73/100

BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

73/ 100

Veridion Score

BUY BIAS · HIGH confidence

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: HIGH · 6/6 factors with data · Fri Aug 28 · last completed session · Markets closed · resumes Mon 9:30 ET

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is JNJ moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move JNJ next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Analyst / Congress / Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Aug 28
Score
Score moved +16
57/NEUTRAL -> 73/BUY BIAS
Veridion score historySource
Aug 1
Analyst
Analyst upgrade
7 SB · 14 B · 10 H -> 7 SB · 15 B · 9 H
Analyst consensus snapshotSource
Jul 30
CongressChecking access
Richard McCormick sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jul 20
CongressChecking access
Ro Khanna purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jun 29
CongressChecking access
Thomas H. Kean, Jr. sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jun 16
CongressChecking access
Ro Khanna purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jun 10
CongressChecking access
Lloyd Doggett sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jun 9
CongressChecking access
Lloyd Doggett purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jun 2
CongressChecking access
Thomas H. Kean, Jr. sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jun 2
CongressChecking access
Ro Khanna purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access

About Johnson & Johnson

PHARMACEUTICAL PREPARATIONS

Listed since

1944

Employees

141K

Country

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$265.78

Day high

$268.38

Day low

$264.27

Previous close

$265.77

52W high

$273.41

-1.83% from high

52W low

$174.16

95% of range

Market cap

$645.9B

P/E

30.43×

EPS

$8.82

Beta

-0.63

Shares out

2.4B

Volume

5.8M

0.82× rel vol

Avg volume

VWAP

$266.77

Price history computed in-house

-0.68%

+4.70%

+20.08%

+51.49%

YTD

+29.69%

SMA 50 $258.14 · above

SMA 200 $233.89 · above

52W position 95%

JNJ overview

Veridion Score

Registered · 2026-08-28

6 of 6 factors measured

Latest receipt rows

Richard McCormick · Sale

13F holders

Vanguard Group, Inc.

Receipt-backed holder profiles

Vanguard Group, Inc. · $49.7B BlackRock, Inc. · $53.9B State Street Corp · $34B Geode Capital Management, LLC · $15B

SEC industry peers

JNJ peers

ABTABBOTT LABORATORIESSEC SIC 2834

ABT Form 10-K · SEC SIC 2834 · Feb 20, 2026 ↗

BMYBRISTOL MYERS SQUIBB COSEC SIC 2834

BMY Form 10-K · SEC SIC 2834 · Feb 11, 2026 ↗

LLYELI LILLY & CoSEC SIC 2834

LLY Form 10-K · SEC SIC 2834 · Feb 12, 2026 ↗

MRKMerck & Co., Inc.SEC SIC 2834

MRK Form 10-K · SEC SIC 2834 · Feb 24, 2026 ↗

PFEPFIZER INCSEC SIC 2834

PFE Form 10-K · SEC SIC 2834 · Feb 26, 2026 ↗

Relationship mapTrace receipt-backed holders and filings around JNJ.Congress disclosuresOpen receipt and filing context for JNJ.MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

JNJ insider activity

Johnson & Johnson

Score

Not evaluated

Pressure

Not evaluated

Filings

Buys / sells

0 / 0

Net value

Not evaluated

Insiders

Cluster

Not evaluated: the SEC filing index could not be read

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

No value-bearing Form 4 rows

The current Form 4 feed did not return value-bearing open-market rows for JNJ.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in JNJ

Congress tracker Open ticker disclosure ledger →

Richard McCormickSell

JNJ · Transaction Jul 30, 2026 · Filed Aug 14, 2026 · $1,001 to $15,000

Official filing ↗

Richard McCormickSell

Johnson & Johnson Common Stock · Transaction Jul 30, 2026 · Filed Aug 14, 2026 · $1,001 to $15,000

Official filing ↗

Ro KhannaBuy

JNJ Common Stock · Transaction Jul 20, 2026 · Filed Aug 7, 2026 · $1,001 to $15,000

Official filing ↗

Thomas H. Kean, Jr.Sell

JNJ · Transaction Jun 29, 2026 · Filed Jul 15, 2026 · $1,001 to $15,000

Official filing ↗

Thomas H. Kean, Jr.Sell

Johnson & Johnson Common Stock · Transaction Jun 29, 2026 · Filed Jul 15, 2026 · $1,001 to $15,000

Official filing ↗

Federal contracts

JNJ contract awards, year to date.

Public federal awards linked to this ticker.

$367.4K

Refresh interval: 12hSource: Federal contract awards

Department of Veterans Affairs

$133.5K

PURCHASE 2 NGEN CARTO3 MAPPING SYSTEMS FOR TVHS NASHVILLE

Apr 16, 2026

Department of Veterans Affairs

$109.0K

INTEGRATED SURGICAL ENERGY PLATFORM SYSTEM

Aug 17, 2026

Department of Veterans Affairs

$100.4K

ENERGY SYSTEM

Jun 30, 2026

Department of Veterans Affairs

$24.6K

LAPAROSCOPIC

Apr 16, 2026

Lobbying spend

JNJ lobbying filings, year to date.

Registered lobbying filings matched to Johnson & Johnson.

$6.7M

Refresh interval: 12hSource: LDA disclosure filings

Health IssuesHealth Issues Budget/Appropriations Copyright/Patent/Trademark Law Enforcement/Crime/Criminal Justice Pharmacy Science/Technology Taxation/Internal Revenue Code Veterans Trade (domestic/foreign)Defense Health Issues Budget/Appropriations Copyright/Patent/Trademark Law Enforcement/Crime/Criminal Justice Pharmacy Science/Technology Taxation/Internal Revenue Code Veterans Trade (domestic/foreign)

Filing

$3.5M

JOHNSON & JOHNSON SERVICES INC

JOHNSON & JOHNSON SERVICES, INC.

Apr 20, 2026

Filing

$1.5M

JOHNSON & JOHNSON SERVICES INC

JOHNSON & JOHNSON SERVICES, INC.

Jan 20, 2026

Filing

$1.4M